Blood Cell RNA-Based Cancer Detection

Recruiting Observational Study
Neoplasms Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Observational
Participants needed
5,000 (estimated)
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Early diagnosis of cancer may provide patients with more treatment options and hopefully prolong survival. The purpose of this multi-center study is to collect peripheral blood from newly diagnosed cancer patients and healthy donors to establish a blood cell RNA-based model for the differentiation of cancer patients and healthy donors. The area under the receiver operating characteristic (AUROC), …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for All the Participants 1. Age 18 years or older 2. Provide informed consent Exclusion Criteria for All the Participants: 1. Pregnancy or lactating women 2. Received a blood transfusion within 1 month 3. Received anti-cancer treatment within 3 years 4. Known prior diagnosis of…
Contacts

Zheng Wang, MD/PhD

+86 27 85726612

zhengwang@hust.edu.cn

CONTACT

Luming Xu

+86 27 85726612

lumingxu@hust.edu.cn

CONTACT